ConcertAI sings a unicorn tune as the FDA-partnered clinical trials software upstart expands

Kyle LaHucik

Senior Reporter

The crescendo is building at ConcertAI as the artificial intelligence life sciences startup reels in its ensemble to boost clinical study diversity, expand decentralized clinical …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

ConcertAI sings a unicorn tune as the FDA-partnered clinical trials software upstart expands

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Biotech seed rounds sink to lowest level in years as industry slump drags on

US drugs rely heavily on ingredients made overseas, new report shows

Pharma's wins and losses in Trump's sprawling executive order on drug prices

Trump pledges his support for a change to the IRA long sought by drugmakers

Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

Con­cer­tAI sings a uni­corn tune as the FDA-part­nered clin­i­cal tri­als soft­ware up­start ex­pands

Senior Reporter

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

ConcertAI sings a unicorn tune as the FDA-partnered clinical trials software upstart expands